BANK OF AMERICA CORP /DE/

Holdings History for Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$36,597,088	1,474,797	+1,153,665	+359%	$24.82	Q4 2025
30 Sep 2025	0%	+0%	$5,208,761	321,132	+66,703	+26%	$16.22	Q3 2025
30 Jun 2025	0%	-0%	$3,335,564	254,429	-440,997	-63%	$13.11	Q2 2025
31 Mar 2025	0%	+0%	$15,299,372	695,426	+646,519	+1300%	$22.00	Q1 2025
31 Dec 2024	0%	-0%	$1,305,817	48,907	-259,144	-84%	$26.70	Q4 2024
30 Sep 2024	0%	+0%	$8,221,882	308,051	+35,257	+13%	$26.69	Q3 2024
30 Jun 2024	0%	+0%	$4,913,020	272,794	+219,031	+407%	$18.01	Q2 2024
31 Mar 2024	0%	-0%	$980,638	53,763	-8,505	-14%	$18.24	Q1 2024
31 Dec 2023	0%	+0%	$681,213	62,268	+21,042	+51%	$10.94	Q4 2023
30 Sep 2023	0%	-0%	$236,225	41,226	-11,075	-21%	$5.73	Q3 2023
30 Jun 2023	0%	-0%	$405,332	52,301	-2,272	-4.2%	$7.75	Q2 2023
31 Mar 2023	0%	+0%	$364,002	54,573	+1,993	+3.8%	$6.67	Q1 2023
31 Dec 2022	0%	+0%	$470,066	52,580	+39,373	+298%	$8.94	Q4 2022
30 Sep 2022	0%	-0%	$130,000	13,207	-26,711	-67%	$9.84	Q3 2022
30 Jun 2022	0%	+0%	$318,000	39,918	+12,368	+45%	$7.97	Q2 2022
31 Mar 2022	0%	-0%	$267,000	27,550	-1,236	-4.3%	$9.69	Q1 2022
31 Dec 2021	0%	+0%	$440,000	28,786	+26,046	+951%	$15.29	Q4 2021
30 Sep 2021	0%	+0%	$46,000	2,740	+2,740	NEW	$16.79	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.